Guggenheim Capital’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.52M | Sell |
31,709
-3,411
| -10% | -$147K | 0.01% | 839 |
|
|
2026
Q1 | $1.29M | Buy |
35,120
+2,835
| +9% | +$134K | 0.01% | 886 |
|
|
2025
Q4 | $1.64M | Buy |
32,285
+2,892
| +10% | +$148K | 0.01% | 735 |
|
|
2025
Q3 | $1.63M | Buy |
29,393
+3,259
| +12% | +$191K | 0.01% | 741 |
|
|
2025
Q2 | $1.8M | Sell |
26,134
-1,776
| -6% | -$121K | 0.01% | 682 |
|
|
2025
Q1 | $1.94M | Buy |
27,910
+5,791
| +26% | +$478K | 0.02% | 648 |
|
|
2024
Q4 | $1.9M | Sell |
22,119
-6,428
| -23% | -$695K | 0.02% | 670 |
|
|
2024
Q3 | $3.4M | Sell |
28,547
-6,861
| -19% | -$915K | 0.02% | 652 |
|
|
2024
Q2 | $5.05M | Buy |
35,408
+2,546
| +8% | +$337K | 0.04% | 513 |
|
|
2024
Q1 | $4.22M | Sell |
32,862
-489
| -1% | -$58.2K | 0.03% | 612 |
|
|
2023
Q4 | $3.45M | Sell |
33,351
-9,614
| -22% | -$951K | 0.03% | 661 |
|
|
2023
Q3 | $3.91M | Sell |
42,965
-1,715
| -4% | -$151K | 0.03% | 572 |
|
|
2023
Q2 | $3.62M | Sell |
44,680
-11,230
| -20% | -$917K | 0.03% | 640 |
|
|
2023
Q1 | $4.45M | Buy |
55,910
+13,690
| +32% | +$971K | 0.04% | 561 |
|
|
2022
Q4 | $2.86M | Sell |
42,220
-2,984
| -7% | -$175K | 0.03% | 725 |
|
|
2022
Q3 | $2.25M | Buy |
45,204
+1,036
| +2% | +$55.5K | 0.02% | 789 |
|
|
2022
Q2 | $2.46M | Buy |
44,168
+2,058
| +5% | +$114K | 0.02% | 810 |
|
|
2022
Q1 | $2.34M | Buy |
42,110
+1,550
| +4% | +$79.5K | 0.01% | 938 |
|
|
2021
Q4 | $2.27M | Sell |
40,560
-3,910
| -9% | -$212K | 0.01% | 997 |
|
|
2021
Q3 | $2.13M | Buy |
44,470
+1,668
| +4% | +$80.6K | 0.01% | 1024 |
|
|
2021
Q2 | $1.79M | Sell |
42,802
-2,518
| -6% | -$97.6K | 0.01% | 1153 |
|
|
2021
Q1 | $1.53M | Buy |
45,320
+428
| +1% | +$15.2K | 0.01% | 1174 |
|
|
2020
Q4 | $1.57M | Sell |
44,892
-21,270
| -32% | -$735K | 0.01% | 1094 |
|
|
2020
Q3 | $2.3M | Sell |
66,162
-6,032
| -8% | -$201K | 0.02% | 834 |
|
|
2020
Q2 | $2.36M | Buy |
72,194
+1,940
| +3% | +$61.9K | 0.02% | 814 |
|
|
2020
Q1 | $2.12M | Sell |
70,254
-14,536
| -17% | -$433K | 0.02% | 768 |
|
|
2019
Q4 | $2.45M | Sell |
84,790
-30,268
| -26% | -$838K | 0.02% | 961 |
|
|
2019
Q3 | $2.97M | Sell |
115,058
-21,030
| -15% | -$532K | 0.02% | 846 |
|
|
2019
Q2 | $3.47M | Sell |
136,088
-36,446
| -21% | -$901K | 0.03% | 792 |
|
|
2019
Q1 | $4.51M | Buy |
172,534
+32,830
| +23% | +$807K | 0.04% | 673 |
|
|
2018
Q4 | $3.22M | Buy |
139,704
+12,796
| +10% | +$284K | 0.03% | 791 |
|
|
2018
Q3 | $2.99M | Sell |
126,908
-1,214
| -0.9% | -$29.6K | 0.02% | 1021 |
|
|
2018
Q2 | $2.95M | Sell |
128,122
-21,930
| -15% | -$521K | 0.02% | 1022 |
|
|
2018
Q1 | $3.69M | Sell |
150,052
-6,998
| -4% | -$184K | 0.01% | 1190 |
|
|
2017
Q4 | $4.21M | Buy |
157,050
+18,098
| +13% | +$460K | 0.01% | 1130 |
|
|
2017
Q3 | $3.35M | Buy |
138,952
+30,332
| +28% | +$685K | 0.01% | 1305 |
|
|
2017
Q2 | $2.33M | Buy |
108,620
+33,460
| +45% | +$675K | 0.01% | 1520 |
|
|
2017
Q1 | $1.29M | Buy |
75,160
+4,690
| +7% | +$81.7K | ﹤0.01% | 1961 |
|
|
2016
Q4 | $1.26M | Buy |
70,470
+2,884
| +4% | +$52.3K | ﹤0.01% | 2011 |
|
|
2016
Q3 | $1.41M | Buy |
67,586
+9,396
| +16% | +$233K | ﹤0.01% | 1859 |
|
|
2016
Q2 | $1.56M | Buy |
58,190
+10,254
| +21% | +$281K | ﹤0.01% | 1734 |
|
|
2016
Q1 | $1.3M | Sell |
47,936
-5,354
| -10% | -$143K | ﹤0.01% | 1876 |
|
|
2015
Q4 | $1.55M | Sell |
53,290
-150,594
| -74% | -$4.17M | ﹤0.01% | 1797 |
|
|
2015
Q3 | $5.53M | Sell |
203,884
-73,210
| -26% | -$2.07M | 0.02% | 981 |
|
|
2015
Q2 | $7.59M | Sell |
277,094
-4,248
| -2% | -$119K | 0.02% | 962 |
|
|
2015
Q1 | $7.51M | Sell |
281,342
-24,156
| -8% | -$556K | 0.02% | 977 |
|
|
2014
Q4 | $6.46M | Sell |
305,498
-32,014
| -9% | -$715K | 0.02% | 1012 |
|
|
2014
Q3 | $8.04M | Sell |
337,512
-15,140
| -4% | -$348K | 0.02% | 986 |
|
|
2014
Q2 | $8.14M | Buy |
352,652
+22,820
| +7% | +$504K | 0.02% | 949 |
|
|
2014
Q1 | $7.53M | Buy |
329,832
+176,562
| +115% | +$3.76M | 0.02% | 946 |
|
|
2013
Q4 | $2.83M | Buy |
153,270
+111,400
| +266% | +$1.94M | 0.01% | 1481 |
|
|
2013
Q3 | $709K | Buy |
41,870
+21,560
| +106% | +$363K | ﹤0.01% | 2275 |
|
|
2013
Q2 | $315K | Buy |
+20,310
| New | +$338K | ﹤0.01% | 2599 |
|
Other funds holding NVO
F
Guggenheim Capital's NVO Position: Q2 2026 in Review
Guggenheim Capital reduced its Novo Nordisk (NVO) stake by 9.7% in Q2 2026, selling an estimated $147K and leaving 31,709 shares worth $1.52M. The position accounts for 0.01% of the portfolio, ranked #839.
Guggenheim Capital first reported a position in NVO in Q2 2013 and has held it in 53 quarters since. The position peaked at $8.14M in Q2 2014. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Guggenheim Capital held 31,709 shares of Novo Nordisk worth $1.52M as of Q2 2026.
- Guggenheim Capital sold 3,411 Novo Nordisk shares in Q2 2026, an estimated $147K.
- Novo Nordisk made up 0.01% of Guggenheim Capital's portfolio in Q2 2026, its #839 holding.
- Guggenheim Capital first reported a position in Novo Nordisk in Q2 2013 and has held it in 53 quarters since.
- Guggenheim Capital's Novo Nordisk position peaked at $8.14M in Q2 2014.
- 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Guggenheim Capital's 13F filing for Q2 2026, filed 12 Aug 2026.